Clinical trial Recruiting at 1 site Interventional Ages 21 to 65

Understanding brain activity related to smoking lapses

Official title: Linking Brain Network Dynamics to Imminent Smoking Lapse Risk and Behavior

Run by Penn State University · NCT05572671 · Data updated 2026-11-12

This study is trying to see how brain activity changes in adults who smoke right before they might slip up and have a cigarette after trying to quit.

Quick facts

Study typeInterventional
Ages21 Years to 65 Years
SexAll
Enrollment150 (estimated)
SponsorPenn State University
Academic / other
Locations1 site (University Park, Pennsylvania)
StatusRecruiting
StartedApril 4, 2023
Main results expectedJuly 2027
Study endsAugust 2027
Registry record updatedMay 5, 2026
Trial IDNCT05572671 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21 to 65 who smoke at least six cigarettes per day and are willing to abstain from nicotine for 12 hours prior to the study.

Probably not a fit

Patients who are not regular smokers or those with contraindications for MRI procedures will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to explore the psychological processes that lead to smoking lapses, which are critical moments when individuals may relapse during a quit attempt. Using functional magnetic resonance imaging (fMRI), the study will measure brain activity patterns in adults who smoke, particularly focusing on changes that occur before a lapse. Participants will undergo a laboratory task designed to model smoking lapse behavior after a 12-hour period of abstinence from cigarettes. The research seeks to link brain dynamics to emotional states and subsequent smoking behavior, addressing a significant gap in understanding smoking relapse.

Why it matters

Potential benefit: If successful, this study could lead to improved strategies for preventing smoking relapse and enhancing cessation efforts.

How similar studies have gone: While the use of fMRI in smoking research is established, this specific approach to linking brain dynamics to smoking lapse behavior is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must be between the ages of 21 and 65.
* Participants must be fluent English speakers.
* Participants must pass an MRI safety screening.
* Participants must report smoking at least six cigarettes per day continuously for at least the 12 preceding months.
* Participants must have a baseline expired-air carbon monoxide exceeding 10 parts per million in order to verify smoking status.

Exclusion Criteria:

* Individuals will be excluded if they report that they are not willing to refrain from using nicotine for 12 hours before the experimental lab visit.
* Individuals will be excluded if they have any known risk from exposure to high-field strength magnetic fields (e.g., pacemakers), any irremovable metallic foreign objects in their body (e.g., braces), or a questionable history of metallic fragments that are likely to create artifact on the MRI scans.

Where it's running

  • The Pennsylvania State University
    University Park, Pennsylvania, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.